EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EffRx Pharmaceuticals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3297
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides commercialized product Binosto, an effervescent tablet for oral solution and treatment of osteoporosis in postmenopausal women. EffRx’s lead development product, EX404 targets polycystic ovarian syndrome in adolescents. The company also offers life cycle management services to pharmaceutical and biotechnology companies. It distributes products through distributors in the US, Australia, South Korea and others. EffRx is headquartered in Schwyz, Switzerland.

EffRx Pharmaceuticals SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Private Equity 13
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
Partnerships 15
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Licensing Agreements 23
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA – Key Competitors 25
EffRx Pharmaceuticals SA – Key Employees 26
EffRx Pharmaceuticals SA – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Corporate Communications 28
Jun 01, 2017: Paolo Agnoluzzi Appointed CFO of EffRx Pharmaceuticals 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA, Key Competitors 25
EffRx Pharmaceuticals SA, Key Employees 26

List of Figures
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Millennium Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Millennium Pharmaceuticals Inc (Millennium), a subsidiary of Takeda Pharmaceutical Company Ltd is a biopharmaceutical company that undertakes research, development, and commercialization of drugs for treating cancer. The company’s product Velcade is used for the treatment of multiple myeloma …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • Kraftwerke Oberhasli AG:企業の戦略的SWOT分析
    Kraftwerke Oberhasli AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Fukuoka Financial Group Inc:企業の戦略・SWOT・財務情報
    Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cosucra Groupe Warcoing SA:企業の戦略・SWOT・財務情報
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • St. James’S Place Plc:企業の戦略・SWOT・財務分析
    St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report Summary St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Applebee’s Restaurants LLC:戦略・SWOT・企業財務分析
    Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report Summary Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sinclair Pharma Plc (SPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collag …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Clean Harbors, Inc. (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oxurion NV (OXUR):企業の財務・戦略的SWOT分析
    Oxurion NV (OXUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Capitol Health Ltd (CAJ):医療機器:M&Aディール及び事業提携情報
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider to the healthcare market.. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, …
  • Akzo Nobel NV (AKZA):企業の財務・戦略的SWOT分析
    Akzo Nobel NV (AKZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Purdue Pharma Canada-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆